Gland Pharma Limited IPO Message Board (Page 23)

Total Anchor placement is around Rs.650 crores whereas total IPO size is nearly Rs.6000 cores. Is it such a big deal,?

Anchor is 1943.8 crore. From where you got figure of 600 crores

If discounts than also thay earn money from back side ..

Anchor ka khod ka pasa nai hota he..

Anchor ke sat % me deal hoti he .

SMALL CAP WORLD FUND, INC -> 6.62%
GOVERNMENT OF SINGAPORE -> 5.32%
NOMURA TRUST AND BANKING CO LTD ->4.16%
GOLDMAN SACHS INDIA LTD ->3.31%
AXIS MUTUAL FUND -> 3.02%
FRANKLIN TEMPLETON MUTUAL FUND -> 3.02%
SBI MUTUAL FUND ->3.02%
NEUBERGER BERMAN MUTUAL FUND ->2.87%
ADITYA BIRLA SUNLIFE MF ->2.84%
ICICI PRUD MUTUAL FUND -> 2.84%
NIPPON INDIA MUTUAL FUND -> 2.84%
KOTAK MUTUAL FUND -> 2.46%
.... and a long list
very impressive anchor placement ????
https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20201106-43

Top 3 anchor investors are foreign investors
USA -> SMALL CAP WORLD FUND, INC -> 6.62%
SINGAPORE -> GOVERNMENT OF SINGAPORE -> 5.32%
JAPAN ->NOMURA TRUST AND BANKING CO LTD ->4.16%

Good Company.
Good fundamentals.
Eps for June 2020 is 20 translate into full year it comes Rs.80. Conservatively 72 to 75.
So pe as on March 2021 will be 22.
It is attractively priced. Pharma industry now very much fancy.
Anchor Investor minimum 75 and above as per my expectations.
Qib response will be good. (My expectation is above 35 times)
After Seeing qib response last day we consider to apply this issue if qib subscribes above 20 times.
Only concern is Chinese promoter.

Rajakumar Sir, thank you for your guidance in this regard.

Dear Lekker
Welcome
Stock market always risk reward. You took risk and reward is in your hand.
We can not take blindly take risk.
This is foreign company, debt free, fundamentally strong, so we took risk.

GMP 52/57

Gmp (50)

Gland Pharma Anchor placement list is out in bse https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20201106-43

Latest premium?

GMP 82-87
Source
https://economictimes.indiatimes.com/markets/ipos/fpos/grey-market-premium-fizzles-out-for-gland-pharma-after-fixing-price-band/articleshow/79078267.cms

Anyone received anchor list??

Discounts make my word ...

High value issue , Low gmp , China owner -- all are reasons to avoid the ipo..

Last GMP Heard : 50/55

Now only Hope is good Anchor List..

Anchor investor list?

Gland pharma only seller

If anyone get the anchor investor list then share.

primum 70/75

primum 75/80

Premium 78-82

At the price band of Rs 1490 to Rs 1500
and that to for 5230cr IPO
we will definately get at lower price
Those HNI who have money , and donot know where to
invest may apply
i am not going to apply in Gland Pharma

views exspressed my own consult the finalncial advisor

@Chem Cho
Yes, I agree the issue size is very large.

Like UTIAMC, it may list in negative zone. By chance, if there will be a listing gain, it will be maximum 5-10% which is negligible. We can't expect a big listing gain from this IPO. Risk reward is not in favour for this IPO.

So, your advice to avoid is the best one in current scenario. Thanks for your valuable suggestions.

Gland Pharma Ltd Ipo:- 2 lack application subject2 26 rs premium.

@Aniket Can I buy NTPC shares to participate in the buyback and would you recommend to buy today if yes

Thanks in advance..Always looking forward for your strategies..

Yes
Thanks.

Trump is losing.
Trump was India friendly &
Biden is china friendly.China sent fund and helped him to win the race.
kamla ka hamla : we will interfere kashmir issue.
- kamla harris
china issued statement in global times to declare dispute as war against India after U.S election depending on cross border situation.china sent 60,000 soldiers at border.

Indo-china relation may worsen even more before listing.so beware.

# check it where gland pharma stands with some large and midcap pharma Cos. :

pharma company : cmp , eps , p/e , p/b , return in %

* gland pharma : 1500 , 50 , 30 , 6 , 21 %
1.glenmark pharma : 500 , 56 , 9 , 1 , 12 %
2.ajanta pharma : 1600 , 62 , 26 , 5 , 19 %
3.aurobindo pharma : 800 , 39 , 21 , 3.5 , 17 %
4.suven pharma : 325 , 17 , 19 , 4.4 , 22 %
5.solara pharma : 1100 , 44 , 25 , 2.6 , 11 %

subscription estimate :

QIB : 3-4X
HNI : < 50 %
RII : < 1x

GMP : 50-55 almost negligible

Lead manager " Haitong sec. " also belongs to china.????
china products may be cheaper but not IPO product.????

First you learn mathematics

what are you going to teach ¿ ????